HCA Healthcare, Inc. (NYSE:HCA) Q4 2019 Earnings Conference Call January 28, 2020 10:00 AM ET Company Participants Mark Kimbrough - VP, IR Samuel Hazen - CEO & Director William Rutherford - EVP & CFO Jonathan Perlin - President, Clinical Services Group & Chief Medical Officer Conference Call Participants Philip Chickering - Deutsche Bank Frank Morgan - RBC Capital Markets Kevin Fischbeck - Bank of America Merrill Lynch A.J. Rice - Crédit Suisse Scott Fidel - Stephens Inc. Ralph Giacobbe - Citigroup Benjamin ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 27-3865930 (State ...

HCA Healthcare, Inc. (NYSE:HCA) Q3 2019 Earnings Conference Call October 29, 2019 10:00 AM ET Corporate Participants Mark Kimbrough - Senior Vice President of Investor Relations Sam Hazen - Chief Executive Officer Bill Rutherford - Chief Financial Officer Conference Call Participants A.J. Rice - Credit Suisse Whit Mayo - UBS Josh Raskin - Nephron Research Pito Chickering - Deutsche Bank Gary Taylor - JPMorgan Justin Lake - Wolfe Research Kevin Fischbeck - Bank of America Ann Hynes - Mizuho Securities Steve ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 27-3865930 (State or o ...

HCA Healthcare, Inc. (NYSE:HCA) Q2 2019 Results Earnings Conference Call July 30, 2019 10:00 AM ET Company Participants Mark Kimbrough - Vice President of Investor Relations Sam Hazen - Chief Executive Officer Bill Rutherford - Executive Vice President, Chief Financial Officer Conference Call Participants Pito Chickering - Deutsche Bank Steve Tanal - Goldman Sachs A.J. Rice - Credit Suisse Justin Lake - Wolfe Research Ralph Giacobbe - Citi Brian Tanquilut - Jefferies Frank Morgan - RBC Capital Markets Josh ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 HCA Healthcare, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or ...

1 Oppenheimer 29th Annual Healthcare Conference Forward Looking Statements and Non-GAAP Financial Measures This presentation may contain certain forward-looking statements provided by Company management. These statements are intended to be covered by the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts, including statements regarding future operations, financial results, ...

1 Raymond James 40th Annual Institutional Investors Conference Forward Looking Statements and Non-GAAP Financial Measures This presentation may contain certain forward-looking statements provided by Company management. These statements are intended to be covered by the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts, including statements regarding future operations, fina ...

Table of Contents Index to Financial Statements UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Commission File Number 1-11239 HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 27-3865930 (State or Other Jurisdiction of Incorporation or Organization) One Park Plaza Nashville, Tennessee Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 Or ☐ TRANSITIO ...

HCA Holdings, Inc. (NYSE:HCA) Q4 2018 Earnings Conference Call January 29, 2019 10:00 AM ET Company Participants Sam Hazen - Chief Executive Officer Bill Rutherford - Chief Financial Officer Mark Kimbrough - Chief Investment Relations Officer Conference Call Participants Justin Lake - Wolfe Research LLC Pito Chickering - Deutsche Bank A.J. Rice - Credit Suisse Securities Whit Mayo - UBS Steve Tanal - Goldman Sachs. Matthew Borsch - BMO Capital Markets Michael Newshel - Evercore ISI Sarah James - Piper Jaff ...